Malvern releases new guidance on the use of automated imaging for agglomerate detection
November 13, 2014
Malvern, UK: Malvern Instruments has released new guidance on using automated image analysis to detect and quantify agglomerates. The ability of uncontrolled agglomeration to substantially impact the performance and value of powder products makes efficient agglomerate detection vital across a number of industries. ‘Identification of agglomerates using automated image analysis’ presents practical strategies for efficiently [...]
Cepheid To Develop Xpert Ebola For Countries Worst Hit By Epidemic
November 13, 2014
SUNNYVALE, Calif. -- Cepheid (NASDAQ: CPHD) today announced that it has been awarded a grant of up to $3.3 million co-financed by the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation to develop Xpert® Ebola, a rapid test that could be run on Cepheid's installed base of more than 3,500 GeneXpert® [...]
Fluorescence-based Mitochondria / Metabolism Assays
November 13, 2014
AMSBIO has signed a strategic marketing agreement with Luxcel Biosciences to distribute their range of 96- and 384-well phosphorescence and fluorescence based assays. These new assay kits enable direct real-time analysis of Mitochondrial Respiration (MitoXpress® Xtra), Glycolysis (pH-Xtra®) and Intracellular Oxygen Concentration (MitoXpress® Intra) – providing the perfect tool kit for monitoring bioenergentics, metabolism, Warburg [...]
Artel Further Enhances ArtelWare™ Software to Provide Liquid Handler Performance Trending
November 13, 2014
Westbrook, Maine -– Artel, the leader in liquid handling quality assurance, introduces ArtelWare v1.2, adding sophisticated tools for liquid handler monitoring with the company’s MVS® Multichannel Verification System. With new, color-coded heat maps for relative inaccuracy and %CV, users can view performance trends over the microplate. These new tools build on other recent ArtelWare enhancements [...]
Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan
November 12, 2014
SEATTLE -- ReachBio Research Labs (a registered trade name of ReachBio LLC, Seattle, WA) announced today that it has signed an agreement with Funakoshi Co., Ltd. (Tokyo, Japan), giving Funakoshi non-exclusive distribution rights to ReachBio's human primary cell product line for the life science research market within Japan. Under a companion agreement, Funakoshi will also [...]
November 12, 2014
Singapore -– Vela Diagnostics announced today that it has completed the listing of its Next-Generation Sequencing (NGS) system with the U.S. Food and Drug Administration (FDA) for clinical use as a class II device. The Vela Diagnostics NGS System comprises the Sentosa® ST401 instruments which provide an automated solution for template preparation and enrichments, the [...]
Susan A. Willetts Joins Cellular Dynamics’ Board of Directors
November 12, 2014
MADISON, Wis. -- Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Susan A. Willetts was elected to the company's board of directors, effective November 6, 2014. Ms. Willetts also will serve as a member of the CDI board's audit committee. Ms. Willetts has been an advisory director of Goldman, Sachs & Co. since July [...]
Single-Tube, Multiplex Amplicon Sequencing for Illumina® platforms
November 12, 2014
Swift Biosciences, Inc. has announced the launch of an early access program for Accel-NGS™ Amplicon Panels for use with Illumina Next Generation Sequencing (NGS) systems. The assays are compatible with FFPE and circulating cell free DNA from 10 ng of genomic DNA. The underlying technology enables hundreds of primer pairs to be amplified in a [...]
November 12, 2014
SANTA CLARA, Calif. -- Affymetrix (NASDAQ:AFFX) announced today the launch of Concurrent Molecular Analysis Profiling (CoMAP™) capability, which enables cancer researchers to gain rapid insight into the functional impact of DNA copy number alterations by combining whole-genome copy number data with gene expression profiles to easily and cost-effectively visualize and identify cancer driver events. Whole-genome [...]
1ST DETECT ANNOUNCES ITS SUCCESSFUL INTRODUCTION OF THE iONTRAC AT THE GULF COAST CONFERENCE
November 12, 2014
AUSTIN, Texas -- 1st Detect, a subsidiary of Astrotech (Nasdaq:ASTC), has launched its disruptive mass spectrometry technology into the petrochemical industry at the esteemed Gulf Coast Conference (GCC). The iONTRAC process monitor has been developed for use within petrochemical industrial processing streams. “Our iONTRAC was very well received at GCC and being recognized to receive [...]

